Febrile UTI and Renal Scarring

Program Description:

This program explores treatment approaches for vesicoureteral reflux (VUR) and the problem of febrile urinary tract infection (UTI) and renal scarring. A potpourri of case studies will highlight the various approaches and provide the basis of lively discussion.

Activity Objectives:

Upon completion of this activity, participants should be able to:

• Explain the different evaluation, imaging, and treatment strategies for VUR based on age and UTI history


• Describe the practices, both medical and personal, that accompany antibiotic prophylaxis


• Differentiate the top-down approach from the bottom-up approach to evaluating UTI in children


• Compare the benefits and risks of antibiotic prophylaxis


• Indicate the prevalence of urinary tract infection after medical treatment options

Faculty:

Martin A. Koyle, MD (Activity Chairman)
Michael Mitchell Endowed Chair in Pediatric Urology
University of Washington
Professor & Chief, Pediatric Urology
Seattle Children’s Hospital
Seattle, Washington

Jennifer M. Abidari, MD
Clinical Associate Professor of Urology
Stanford University
Stanford, California
Chief, Pediatric Urology
Santa Clara Valley Medical Center
San Jose, California

Jack S. Elder, MD
Clinical Professor of Urology
Case Western Reserve University School of Medicine
Cleveland, Ohio
Chief of Urology, Henry Ford Health System
Associate Director, Vattikuti Urology Institute
Department of Urology, Children’s Hospital of Michigan
Detroit, Michigan

Tej K. Mattoo, MD
Professor of Pediatrics
Wayne State University School of Medicine
Chief, Pediatric Nephrology and Hypertension
Children’s Hospital of Michigan
Detroit, Michigan

Hans G. Pohl, MD
Associate Professor, Urology and Pediatrics
George Washington University
Attending
Children’s National Medical Center
Washington, DC

Pramod P. Reddy, MD
Associate Professor of Urology
University of Cincinnati College of Medicine
Division Director of Pediatric Urology
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio

Steven J. Skoog, MD
Professor of Surgery and Pediatrics
Oregon Health & Sciences University
Director of Pediatric Urology
Doembecher Children’s Hospital
Portland, Oregon

Warren T. Snodgrass, MD
Professor of Urology
University of Texas Southwestern Medical Center
Chief, Pediatric Urology
Children’s Medical Center
Dallas, Texas

Disclosures:

In accordance with the Accreditation Council for Continuing Medical Education, Hemedicus requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Faculty disclosures appear below.

Jennifer M. Abidari, MD, has no real or apparent conflicts of interest to report.
Jack S. Elder, MD, has no real or apparent conflicts of interest to report.
Martin A. Koyle, MD, has no real or apparent conflicts of interest to report.
Tej K. Mattoo, MD, receives grant support from the NIH.
Hans G. Pohl, MD, has no real or apparent conflicts of interest to report.
Pramod P. Reddy, MD, has no real or apparent conflicts of interest to report.
Steven J. Skoog, MD, has no real or apparent conflicts of interest to report.
Warren J. Snodgrass, MD, has no real or apparent conflicts of interest to report.

The Hemedicus staff involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity.

The Hemedicus staff involved in content review of this activity have no financial relationships with any commercial interests that are relevant to this activity.

To resolve identified conflicts of interest, the educational content was fully reviewed by Hemedicus. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The content and views presented in this educational activity are those of the presenters and do not necessarily reflect those of Hemedicus or the supporter. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained in this educational activity.

This activity is sponsored by Hemedicus, Inc.


This educational activity is made possible by an educational grant from Oceana Therapeutics, Inc.


If you have any questions relating to the accreditation of this activity, please contact Robin Simak, Senior Director, CME Compliance, Hemedicus, rsimak@hemedicus.com

Instructions:

To obtain credit, a score of 70% or better is required. This CME activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH^® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.